Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access

Timothy mutation affects tightly sealing point of CaV1.2 activation gate

  • Katrin Depil1Email author,
  • Stanislav Beyl1,
  • Anna Stary-Weinzinger1,
  • Annette Hohaus1,
  • Eugen Timin1 and
  • Steffen Hering1
BMC Pharmacology201111(Suppl 2):A12

https://doi.org/10.1186/1471-2210-11-S2-A12

Published: 5 September 2011

Background

The Timothy syndrome (TS) mutations G402S and G406R abolish inactivation of CaV1.2 and cause multiorgan dysfunction and lethal arrhythmias.

Methods

In order to gain insights into the consequences of the G402S mutation on structure and function of the channel, we systematically mutated the corresponding G432 and the homologous S6 positions of the other three domains of the rabbit channel and applied homology modeling.

Results

Homology modeling revealed that G432 forms part of a highly conserved structure motif (G/A/G/A) of small residues in homologous positions of all four domains (G432 (IS6), A780 (IIS6), G1193 (IIIS6), A1503 (IVS6)). In contrast, corresponding mutations in domains II, III and IV induced parallel shifts of activation and inactivation curves indicating a preserved coupling between both processes. Disruption between coupling of activation and inactivation was specific for mutations of G432 in domain I. Mutations of G432 removed inactivation irrespective of the changes in activation. In all four domains residues G/A/G/A are in close contact with larger bulky amino acids from neighboring S6 helices.

Conclusions

These interactions apparently provide adhesion points thereby tightly sealing the activation gate of CaV1.2 in the closed state. Such a structural hypothesis is supported by changes in activation gating induced by mutations of the G/A/G/A residues.

Authors’ Affiliations

(1)
Institute of Pharmacology and Toxicology, University of Vienna

Copyright

© Depil et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement